Participants in new trial lost weight and did not suffer gastrointestinal byproducts associated with GLP-1 medicines ...
The drug, known as camizestrant, can be used in combination with other cancer medicines in patients who have a genetically driven form of metastatic breast cancer. AstraZeneca said camizestrant, which ...
Daiichi Sankyo Co Ltd on Wednesday said that its breast cancer drugs, Enhertu and Datroway, which are being developed in ...
Advancements in COPD treatment are offering relief to thousands of Kentuckians by targeting inflammation directly without the ...
Get COVID-19 vaccine side-effects latest news, Article video and Photos on COVID-19 vaccine side-effects Explore latest health updates, news, information from TheHealthSite.com ...
New drug shows promise in reducing COPD symptoms in former and current smokers, clinical trials show
A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to ...
A combination of the company’s breast cancer drug Etcamah did not delay worsening of the disease enough to meet the SERENA-4 ...
NVCT stock surged on NXP100 PNH deal. Explore catalysts, dilution risk, and pipeline outlook for NXP100/NXP200/NXP900—read ...
GSK reported good clinical trial results with two of its lung cancer therapies – Jideytro and risvutatug rezetecan (ris-rez) ...
One expert told Newsweek the new approach is a "transformative shift" for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results